The level of LYVE-1 mRNA expression in tumour samples was shown to be a sensitive indicator of the level of lymphangiogenesis in vivo (Cunnick et al, 2001; Van der Auwera et al, 2004). This evidence concerns the gene LYVE1 and neoplasm.